• Science
  • Approach
  • About Us
  • Pipeline
  • News
  • Join Our Team
  • Contact
  • Menu Menu
Menu
menu bar menu bar

Alpha-9 Oncology Doses First Patient in Phase 1 Clinical Trial Evaluating GRPR-Targeted Radiotherapeutics Across Multiple Solid Tumors

185 Dartmouth St, 6th Floor
Boston, MA 02116

27 E 7th Ave, Suite 300
Vancouver, BC V5T 1M4

  • Science
  • Approach
  • About Us
  • Pipeline
  • News
  • Join Our Team
  • Contact

©2026 Alpha-9 Oncology, Inc.

All rights reserved.

Terms of Use | Privacy Policy | Cookie Policy

  • Science
  • Approach
  • About Us
  • Pipeline
  • News
  • Join Our Team
  • Contact